Myriad Genetics Launches Prostate Cancer Test Combining Genomics and AI
The test combines genomic risk assessment and digital pathology analysis to help clinicians tailor monitoring strategies.
Read More
Search Results for: prostate cancer
Gene Test Identifies Breast Cancer Patients Who Can Safely Skip Chemotherapy
Findings from the OPTIMA trial show that the Prosigna test identifies patients who can safely skip chemotherapy and use hormone therapy alone.
Read More
Urine Test Reduced Unnecessary Prostate Biopsies by 64%, Study Finds
Researchers reported that the test reduced unnecessary biopsies by up to 64% without compromising detection of aggressive prostate cancers.
Read More
Tempus Launches Open-Source Digital Pathology Consortium with Major Medical Centers
The initiative aims to standardize digital pathology through an open-source platform and image management system.
Read More
New AI Test Predicts Mortality Risk in Metastatic Prostate Cancer
The digital pathology platform provides patient-specific risk estimates to help clinicians tailor treatment for metastatic hormone-sensitive disease.
Read More